ASRM 2007 Annual Meeting 

Commercially Supported Symposia

The Commercially Supported Symposia presented are accredited within the ASRM Annual Meeting format. Although topics were suggested by the indicated supporters, members of the Program Committee selected the Program Directors who invited the speakers and developed the programs.

Monday, October 15, 2007

12:00 pm–1:30 pm

LUNCHEON SYMPOSIUM
Controversies in HPV Vaccination
Room: Hall A

Chair: Samantha M. Pfeifer, M.D.

Faculty:
Mark Spitzer, M.D.
John W. Ward, M.D.

Supported by an educational grant from Merck & Co., Inc.

Needs Assessment & Symposium Description: Human papilloma virus (HPV) has been shown to be a causative agent in the development of anogenital warts, intraepithelial neoplasia and invasive cancers. A quadravalent HPV vaccine has been approved recently for use in young women ages 11-26 with the intent of protecting against the most common subtypes of HPV implicated in anogenital disease (types 6,11,16,18). This symposium will explore the recent information regarding the efficacy of the vaccine as well as discuss controversies regarding who else should be vaccinated, whether vaccination should be mandated, and if there is a role for the vaccine in protecting against HPV related disease in other sites of the body.

Learning Objectives: 
At the conclusion of the Symposium, participants should be able to:

1. Discuss the recent information regarding the efficacy of the HPV quadravalent vaccine.

2. Identify other individuals who would potentially benefit from the vaccine.

3. Analyze the risks and benefits of mandating the vaccine.

4. Assess the benefit of the vaccine for non-anogenital HPV related disease.

Back to the Top